{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:35:00Z","timestamp":1792438500664,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":43,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Investigaci\u00f3n Cl\u00ednica"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ric.2025.100022","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:18:04Z","timestamp":1761671884000},"page":"100022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Geniposide reverses oxaliplatin resistance in colorectal cancer via suppression of PI3K\/AKT pathway"],"prefix":"10.1016","volume":"77","author":[{"given":"Siyuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ric.2025.100022_bib0160","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.7150\/jca.107117","article-title":"Sleep health: an unappreciated key player in colorectal cancer","volume":"16","author":"Liu","year":"2025","journal-title":"J Cancer"},{"key":"10.1016\/j.ric.2025.100022_bib0165","doi-asserted-by":"crossref","DOI":"10.1177\/10732748211041221","article-title":"Epidemiology and survival of colorectal cancer in Lebanon: a sub-national retrospective analysis","volume":"28","author":"Chatila","year":"2021","journal-title":"Cancer Control"},{"issue":"7","key":"10.1016\/j.ric.2025.100022_bib0170","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.trecan.2024.05.001","article-title":"Advancements in combining targeted therapy and immunotherapy for colorectal cancer","volume":"10","author":"Singh","year":"2024","journal-title":"Trends Cancer"},{"issue":"11","key":"10.1016\/j.ric.2025.100022_bib0175","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15112620","article-title":"Colorectal cancer: disease process, current treatment options, and future perspectives","volume":"15","author":"Adebayo","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ric.2025.100022_bib0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118294","article-title":"GOLPH3 inhibition reverses oxaliplatin resistance of colon cancer cells via suppression of PI3K\/AKT\/mTOR pathway","volume":"260","author":"Yu","year":"2020","journal-title":"Life Sci"},{"issue":"6","key":"10.1016\/j.ric.2025.100022_bib0185","doi-asserted-by":"crossref","DOI":"10.3390\/nu16060797","article-title":"Research progress of plant-derived natural products against drug-resistant cancer","volume":"16","author":"Liu","year":"2024","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.ric.2025.100022_bib0190","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/gerona\/glad066","article-title":"Geniposide-rich Gardenia jasminoides Ellis fruit extract increases healthspan in Caenorhabditis elegans","volume":"78","author":"Choi","year":"2023","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"10","key":"10.1016\/j.ric.2025.100022_bib0195","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22101689","article-title":"A review on the phytochemistry, pharmacology, pharmacokinetics and toxicology of geniposide, a natural product","volume":"22","author":"Shan","year":"2017","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.ric.2025.100022_bib0200","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3892\/etm.2022.11642","article-title":"Geniposide inhibits cell proliferation and migration in human oral squamous carcinoma cells via AMPK and JNK signaling pathways","volume":"24","author":"Bai","year":"2022","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.ric.2025.100022_bib0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111509","article-title":"Evaluation of inhibitory effects of geniposide on a tumor model of human breast cancer based on 3D printed Cs\/Gel hybrid scaffold","volume":"119","author":"Lv","year":"2021","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.ric.2025.100022_bib0210","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1911311","article-title":"Effects of sensitized sorafenib with a paeoniflorin and geniposide mixture on liver cancer via the NF-\u03baB-HIF-2\u03b1-SerpinB3 pathway","volume":"2022","author":"Li","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.ric.2025.100022_bib0215","doi-asserted-by":"crossref","first-page":"110077","DOI":"10.1016\/j.intimp.2023.110077","volume":"118","author":"Kimura","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.ric.2025.100022_bib0220","doi-asserted-by":"crossref","first-page":"37","DOI":"10.31083\/j.fbl2802037","article-title":"To investigate the occurrence and development of colorectal cancer based on the PI3K\/AKT\/mTOR signaling pathway","volume":"28","author":"Zhong","year":"2023","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"11","key":"10.1016\/j.ric.2025.100022_bib0225","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/13543784.2019.1676726","article-title":"Targeting AKT for cancer therapy","volume":"28","author":"Shariati","year":"2019","journal-title":"Expert Opin Investig Drugs"},{"issue":"5","key":"10.1016\/j.ric.2025.100022_bib0230","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1007\/s11033-021-06458-y","article-title":"Cross-talk between non-coding RNAs and PI3K\/AKT\/mTOR pathway in colorectal cancer","volume":"48","author":"Moafian","year":"2021","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.ric.2025.100022_bib0235","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/OTT.S152818","article-title":"RACKI induces chemotherapy resistance in esophageal carcinoma by upregulating the PI3K\/AKT pathway and Bcl-2 expression","volume":"11","author":"Liu","year":"2018","journal-title":"Onco Targets Ther"},{"issue":"1","key":"10.1016\/j.ric.2025.100022_bib0240","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12094-022-02922-8","article-title":"Oxaliplatin inhibits colorectal cancer progression by inhibiting CXCL11 secreted by cancer-associated fibroblasts and the CXCR3\/PI3K\/AKT pathway","volume":"25","author":"Lu","year":"2023","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"10.1016\/j.ric.2025.100022_bib0245","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-022-00902-6","article-title":"Downregulation of MEIS1 mediated by ELFN1-AS1\/EZH2\/DNMT3a axis promotes tumorigenesis and oxaliplatin resistance in colorectal cancer","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"10.1016\/j.ric.2025.100022_bib0250","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3892\/etm.2016.4011","article-title":"Geniposide reverses multidrug resistance in vitro and in vivo by inhibiting the efflux function and expression of P-glycoprotein","volume":"13","author":"Huang","year":"2017","journal-title":"Exp Ther Med"},{"issue":"8","key":"10.1016\/j.ric.2025.100022_bib0255","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10081948","article-title":"Plant-derived bioactive compounds in colorectal cancer: insights from combined regimens with conventional chemotherapy to overcome drug-resistance","volume":"10","author":"Gavrilas","year":"2022","journal-title":"Biomedicines"},{"issue":"17","key":"10.1016\/j.ric.2025.100022_bib0260","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.7150\/ijms.51329","article-title":"Geniposide inhibits proliferation and induces apoptosis of diffuse large B-cell lymphoma cells by inactivating the HCP5\/miR-27b-3p\/MET axis","volume":"17","author":"Hu","year":"2020","journal-title":"Int J Med Sci"},{"issue":"1","key":"10.1016\/j.ric.2025.100022_bib0265","doi-asserted-by":"crossref","first-page":"188569","DOI":"10.1016\/j.bbcan.2021.188569","article-title":"Targeting Bcl-2 for cancer therapy","volume":"1876","author":"Zhang","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"5","key":"10.1016\/j.ric.2025.100022_bib0270","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23051069","article-title":"Lactobacillus casei strain Shirota enhances the in vitro antiproliferative effect of geniposide in human oral squamous carcinoma HSC-3 Cells","volume":"23","author":"Qian","year":"2018","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ric.2025.100022_bib0275","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cbi.2009.05.009","article-title":"Inhibitory effect of penta-acetyl geniposide on C6 glioma cells metastasis by inhibiting matrix metalloproteinase-2 expression involved in both the PI3K and ERK signaling pathways","volume":"181","author":"Huang","year":"2009","journal-title":"Chem Biol Interact"},{"issue":"1","key":"10.1016\/j.ric.2025.100022_bib0280","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","article-title":"The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis","volume":"15","author":"Huang","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"5","key":"10.1016\/j.ric.2025.100022_bib0285","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1142\/S0192415X25500600","article-title":"Geniposide suppresses tumor progression through DUOX1-mediated ferroptosis in hepatocellular carcinoma","volume":"53","author":"Luo","year":"2025","journal-title":"Am J Chin Med"},{"key":"10.1016\/j.ric.2025.100022_bib0290","doi-asserted-by":"crossref","DOI":"10.1007\/s10528-025-11030-5","article-title":"Geniposide inhibits non-small cell lung cancer by regulating proliferation, apoptosis, invasion, migration, epithelial-mesenchymal transition, and cancer stem-like cell property via Wnt\/\u03b2-catenin pathway","author":"He","year":"2025","journal-title":"Biochem Genet"},{"issue":"12","key":"10.1016\/j.ric.2025.100022_bib0295","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.4161\/cc.7.12.6166","article-title":"Targeting prostate cancer based on signal transduction and cell cycle pathways","volume":"7","author":"Lee","year":"2008","journal-title":"Cell Cycle"},{"issue":"13","key":"10.1016\/j.ric.2025.100022_bib0300","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1200\/JCO.2008.20.0766","article-title":"Targeting the mTOR signaling network for cancer therapy","volume":"27","author":"Meric-Bernstam","year":"2009","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.ric.2025.100022_bib0305","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015222","article-title":"Network pharmacology and bioinformatics study of geniposide regulating oxidative stress in colorectal cancer","volume":"24","author":"Wu","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ric.2025.100022_bib0310","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1158\/1535-7163.MCT-18-0196","article-title":"Genipin enhances the therapeutic effects of oxaliplatin by upregulating BIM in colorectal cancer","volume":"18","author":"Kim","year":"2019","journal-title":"Mol Cancer Ther"}],"container-title":["Revista de Investigaci\u00f3n Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034837625004784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034837625004784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T02:11:38Z","timestamp":1763604698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034837625004784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0034837625004784"],"URL":"https:\/\/doi.org\/10.1016\/j.ric.2025.100022","relation":{},"ISSN":["0034-8376"],"issn-type":[{"value":"0034-8376","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Geniposide reverses oxaliplatin resistance in colorectal cancer via suppression of PI3K\/AKT pathway","name":"articletitle","label":"Article Title"},{"value":"Revista de Investigaci\u00f3n Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ric.2025.100022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubiran.","name":"copyright","label":"Copyright"}],"article-number":"100022"}}